Literature DB >> 6467242

Thermal biology and physiology in clinical hyperthermia: current status and future needs.

G C Li.   

Abstract

The current status and needs of thermal biology and physiology as related to clinical hyperthermia are summarized. Emphasis is placed on heat-induced modification of blood flow and microenvironment in tissues, on the biological effects of heat and X-rays, and on the relationship between drug resistance, heat resistance, and thermotolerance in thermochemotherapy. Results from recent studies investigating the relationships between thermotolerance and heat shock proteins in tissue culture cell lines, in rodent tumors, and in normal tissues are presented. These data strongly suggest that the levels of Mr 70,000 heat shock protein can be used as an assay to predict the thermal sensitivity of tissues during fractionated hyperthermia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467242

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

Review 1.  Hyperthermia in cancer therapy.

Authors:  J Otte
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

2.  Enhanced radioinduced cytotoxicity of cultured human bladder cancer cells using 43 degrees C hyperthermia or anticancer drugs.

Authors:  K Nakajima; H Hisazumi
Journal:  Urol Res       Date:  1987

Review 3.  Heat shock proteins and drug resistance.

Authors:  S A Fuqua; S Oesterreich; S G Hilsenbeck; D D Von Hoff; J Eckardt; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Effect of mitomycin C, verapamil, and hyperthermia on human gastric adenocarcinoma.

Authors:  I B Shchepotin; R R Buras; R J Nauta; M Shabahang; S R Evans
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Radiofrequency treatment alters cancer cell phenotype.

Authors:  Matthew J Ware; Sophia Tinger; Kevin L Colbert; Stuart J Corr; Paul Rees; Nadezhda Koshkina; Steven Curley; H D Summers; Biana Godin
Journal:  Sci Rep       Date:  2015-07-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.